Veterinary Medicines

PENICILLIN-STREPTOMYCIN 20-20/ANAFASIS ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ

Authorised
  • Benzylpenicillin procaine monohydrate
  • Dihydrostreptomycin sulfate
  • Procaine hydrochloride
Download as PDF

Product identification

Medicine name:
PENICILLIN-STREPTOMYCIN 20-20/ANAFASIS ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
  • Benzylpenicillin procaine monohydrate
  • Dihydrostreptomycin sulfate
  • Procaine hydrochloride
Target species:
  • Cat
  • Dog
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Benzylpenicillin procaine monohydrate
    200000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Dihydrostreptomycin sulfate
    200.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Procaine hydrochloride
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cat
      • Not applicable
        no withdrawal period
    • Dog
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Anafasis Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Uplab Pharmaceutical Company Ltd.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 79797/22-07-2022/K-0066001
Date of authorisation status change: